Study results suggest that the accuracy of the FreeStyle Libre 14-day flash glucose monitoring system is adequate for patients with type 1 diabetes during its entire lifetime, although it tends to be less so during the beginning and end of its use.
Giving people with type 2 diabetes “wear-and-forget” masked flash glucose monitoring to allow their healthcare providers access to detailed glucose profiles is feasible in primary care, but it is not clear how beneficial this is, show the results of the GP-OSMOTIC trial.
Flash glucose monitoring significantly reduces time in hyperglycemia or hypoglycemia in people with diabetes at high risk for either outcome, with the benefit sustained for at least 6 months, real-world study data show.
Research shows that if people with diabetes recheck their glucose levels within 1 hour after receiving a low blood glucose alert from their flash glucose monitor it substantially reduces their risk for experiencing a long period of hypoglycemia.
Children and adolescents with type 1 diabetes using a predictive low-glucose management system have less hypoglycemia and fewer hypoglycemic events than those managed using sensor-augmented pump therapy alone, according to a 6-month trial.